Nissan Motor Stock News
¥362.40
1.63%
yesterday
Tokyo,
Nov 21, 07:15 am CET
Nissan Motor Stock News
Negative
Reuters
●
4 days ago
Japan's Nissan will cut production by another 1,400 vehicles at its Kyushu plant next week, as the fallout from chip supply disruptions linked to Chinese-owned Nexperia continues to affect its domestic operations, a person familiar with the matter said.
Negative
Reuters
●
8 days ago
S&P Global Ratings said on Friday it has downgraded its rating of Nissan Motor's credit by one notch on continuing pressure on its profitability, while taking a negative view of the outlook for the Japanese automaker.
Negative
Reuters
●
8 days ago
Nissan will eliminate 87 positions at its European regional office in France, a company document and internal emails showed, as part of CEO Ivan Espinosa's global restructuring and turnaround plan that includes a 15% cut in headcount.
Positive
Reuters
●
9 days ago
Nissan Motor is considering a joint vehicle and powertrain development with Honda Motor in the United States, Nissan CEO Ivan Espinosa told the Nikkei business daily on Thursday.
Negative
WSJ
●
16 days ago
The Japanese carmaker posted its fifth straight quarterly net loss, partly because of U.S. tariffs.
Positive
Reuters
●
16 days ago
Nissan Motor posted a 61% rise in second-quarter operating profit from a year earlier on Thursday as efforts to reduce fixed costs as part of its turnaround plan helped it avoid a loss.
Positive
Reuters
●
16 days ago
Nissan Motor has concluded a 97 billion yen ($643 million) deal to sell and lease back its global headquarters in Yokohama, Japan, as part of its business restructuring plans, the automaker said on Thursday.
Neutral
Business Wire
●
17 days ago
VODNJAN, Croatia--(BUSINESS WIRE)--Nissan has redefined customer engagement by partnering with global cloud communications platform Infobip to pioneer an agentic AI campaign.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
